Reach Us +44-1625-708989
Editor - Dinender K. Singla | University of Central Florida | 2953
ISSN: 2155-9538

Journal of Bioengineering & Biomedical Science
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Relevant Topics

Dinender K. Singla

Dinender K. Singla
Dinender K. Singla
Associate Professor of Medicine
College of Medicine, Biomolecular Science Center
University of Central Florida
Orlando, USA

University of Central Florida


Dr. Dinender Singla received his B.Sc. and M.Sc. degrees from Punjabi University, Patiala, India and his PhD from the Post Graduate Institute of Medical Education and Research, Chandrigarh, India, the last in 1996. He held postdoctoral fellowship positions in the Department of Physiology, University of Manitoba, the Faculty of Medicine, University of Ottawa, and at the University of Alberta, all in Canada from 1996-2002. He was a Research Assistant Professor of Medicine at the University of Wisconsin in Madison from 2002-2004 and then an Assistant Professor of Medicine at the University of Vermont from 2004-2007. He was appointed as an Associate Professor of Medicine at the University of Central Florida in July 2007. His major area of research is related to cardiac regeneration and apoptosis in the animal models of Myocardial Infarction, Doxorubicin induced cardiomyopathy and diabetes. He currently held multiple grants from the NIH. He is serving on few editorial boards for cell biology journals. He is an author or coauthor on various papers and published abstracts. He is a reviewer for NIH and AHA study sections and also a manuscript reviewer of the number of major journals.

Research Interest

Novel therapeutic approaches using cell transplantation are being studied to regenerate injured myocardium. Embryonic stem (ES) or induced pluripotent stem (iPS) cells may have an advantage over adult stem cells because these cells exhibit long-term proliferation in vitro, and potentially can provide an unlimited supply of tissue to meet human transplantation needs.



Global Speakers in the subject

Global Experts in the subject

Relevant Conferences